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Key point summary 
• NMDA receptors (NMDARs) are key molecules for controlling neuronal plasticity, learning 
and memory processes. Their function is impaired during Alzheimer’s disease (AD) but the exact 
consequence on synaptic function is not yet fully identified. 
• An important hallmark of AD onset is represented by the neuronal accumulation of Amyloid 
Beta42 oligomers (Abeta42) that we have recently shown to be responsible for the increased 
intracellular Ca2+ concentration through Ryanodine Receptors (RyRs) 
• Here we characterized the effects of Abeta42 oligomers on NMDA synapses showing 
specific pre- and post-synaptic functional changes that lead to a potentiation of basal and 
synchronous NMDA synaptic transmission. 
• These overall effects can be abolished by decreasing Ca2+ release from RyRs with specific 
inhibitors that we propose as new pharmacological tools for AD treatment. 
Abstract
We have recently shown that Abeta42 oligomers (Abeta42) cause calcium dysregulation in 
hippocampal neurons by stimulating Ca2+ release from ryanodine receptors (RyRs) and inhibiting 
Ca2+ entry through NMDA receptors (NMDARs). Here, we found that Abeta42 decreases the 
average NMDA-activated inward current and that Ca2+-entry through NMDARs is accompanied by 
Ca2+ release from the stores. The overall amount of [Ca2+]i increase during NMDA application is 
50% associated to RyRs opening and 50% to NMDARs activation. Addition of Abeta42 does not 
change this proportion. We estimated the number of NMDARs expressed in hippocampal neurons 
and their unitary current. We found that Abeta42 decreases the number of NMDARs without 
altering their unitary current. Paradoxically, the oligomer increases the size of electrically evoked 
eEPSCs induced by NMDARs activation. We found that this is the consequence of the increased 
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rate of glutamate release (p) and number of release sites (N) of NMDA synapses, while the quantal 
size (q) is significantly decreased as expected from the decreased number of NMDARs. An 
increased number of release sites induced by Abeta42 is also supported by the increased size of the 
ready releasable pool (RRP) and by the enhanced percentage of paired pulse depression (PPD). 
Interestingly, the RyRs inhibitor dantrolene prevents the increase of PPD induced by Abeta42 
oligomers. In conclusion, Abeta42 up-regulates NMDA synaptic responses with a mechanism 
involving RyRs that occurs during the early stages of AD onset. This suggests that new selective 




Accumulation of amyloid beta (Abeta) oligomers derived from amyloid precursor protein (APP) 
processing induces neuronal Ca2+ dysregulation and synaptic dysfunction and is considered one of 
the better defined hallmarks of Alzheimer’s disease (AD). Abeta oligomers cause dysregulation of 
Ca2+ homeostasis, neuronal cell death and consequent impairment of memory formation. Ca2+ 
dyshomeostasis induced by Abeta oligomers suggests some priority in the development of early 
strategies for the treatment of Ca2+-mediated neuronal impairments. Uncontrolled increase of 
intracellular Ca2+ concentration ([Ca2+]i) may result from the alteration of different pathways of 
Ca2+ entry through the plasma membrane or Ca2+ release from Ca2+ stores. During the past fifteen 
years, data have been accumulated concerning the impairment of both mechanisms of [Ca2+]i 
increase during AD. Specifically, Abeta oligomers affect Ca2+ entry through NMDARs (Snyder et 
al., 2005; Zhang et al., 2016) and/or voltage-gated calcium channels (VGCCs) (Nimmrich et al., 
2008; Thibault et al., 2012; Wang & Mattson, 2013). 
NMDARs are key regulators of memory formation (Costa et al., 2012). They are upregulated 
during AD onset, causing increased [Ca2+]i (Danysz & Parsons, 2012), impaired synaptic function 
and accelerated neuronal death. VGCCs are also targeted by Abeta oligomers, but opposite 
evidence suggests either an up- or down-regulation depending on the experimental procedure and 
brain region considered (Thibault et al., 2012; Wang & Mattson, 2013). The alternative mechanism 
of [Ca2+]i increase associated with RyRs and IP3 receptors (IP3Rs) activation is impaired during AD 
onset (Mattson, 2010). RyRs and IP3Rs are not equally distributed along the ER membrane. IP3Rs 
are preferentially located in the somatic region and possibly involved in the control of Ca2+-
dependent excitatory phenomena while RyRs are preferentially expressed in the ER close to the 
synaptic sites (Chakroborty et al., 2013) and likely involved in the control of [Ca2+]i governing 
synaptic activity. Our present goal on synaptic dysfunction induced by Abeta42 and associated with 
the functional coupling of RyRs to IP3Rs (Berridge, 2011), RyRs to NMDARs (Goussakov et al., 
2010) and VGCCs (Kim et al., 2007), is primarily focused on the RyRs impairment induced by 
Abeta oligomers during AD onset. 
We have previously observed that spontaneous firing and intracellular Ca2+ homeostasis of 
hippocampal neuronal network was altered after incubation with Abeta42 and concluded that a 
target of Abeta42 is the postsynaptic NMDAR activity (Gavello et al., 2018). Starting from these 
considerations, here we performed patch-clamp and Ca2+ imaging recordings to test how the 
neurotoxic oligomer acts on NMDA-type glutamatergic synapses. We found that Abeta42 alters 
NMDA synapses by differently targeting pre and postsynaptic sites. In particular, we found that 
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Abeta42 reduces the number of postsynaptic NMDARs without altering their unitary current. These 
inhibitory effects contrast with the presynaptic potentiating action of Abeta42 that produces 
intracellular calcium transient increases (Gavello et al. 2018) that can account for the increased 
eEPSCs amplitude during asynchronous spontaneous firing or electrical stimulation. Using multiple 
probability fluctuation analysis (MPFA) we next observed that Abeta42 increases both the release 
probability (p) and the number of release sites (N) of NMDA synapses, justifying the enhanced 
NMDA-mediated eEPSCs amplitude. In line with this, through the analysis of cumulative eEPSCs 
during high frequency stimulation (10 Hz) we found that Abeta42 increases the size of the ready-
releasable pool (RRP). Interestingly, administration of RyRs inhibitor dantrolene restores p and the 
size of eEPSCs to control values, suggesting that RyRs play a key role in the altered mechanisms of 
NMDA-type synaptic transmission induced by Abeta42. In conclusion, our data prompt a valuable 
description of how Abeta42 up-regulates NMDA synaptic responses with a mechanism involving 
RyRs (Danysz & Parsons, 2012) during the early stages of AD onset. This also suggests that 




Ethical approval was obtained for all experimental protocols from the University of Torino Animal 
Care and Use Committee, Torino, Italy. All experiments were conducted in accordance with the 
National Guide for the Care and Use of Laboratory Animals adopted by the Italian Ministry of 
Health. All animals had free access from the shelter to water and food. Every effort was made to 
minimize animal suffering and the number of animals used. For removal of tissues, animals were 
deeply anaesthetized with CO2 inhalation at fixed concentration and rapidly killed by cervical 
dislocation.
Cell culture 
All experiments were performed in accordance with the guidelines established by the National 
Council on Animal Care and approved by the local Animal Care Committee of Turin University. 
Hippocampal neurons were obtained from C57BL/6 mouse 18-day embryos. Hippocampus was 
rapidly dissected under sterile conditions, kept in cold HBSS (4ºC) with high glucose, and then 
digested with papain (0.5 mg/ml) dissolved in HBSS plus DNAse (0.1 mg/ml) as previously 
described (Allio et al., 2015). Isolated cells were plated at the final density of 1200 cells/mm2. 
Recordings were carried out at DIV 18.  
Patch Clamp experiments 
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Patch electrodes, fabricated from thick borosilicate glasses (Hilgenberg, Mansifield, Germany), 
were pulled to a final resistance of 3-5 M . Patch Clamp recordings were performed in whole cell 
configuration using a Multiclamp 700-B amplifier connected to a Digidata 1440 and governed by 
the pClamp10 software (Axon Instruments, Molecular Devices Ltd, USA). 
Experiments were performed at room temperature (22-24 °C) in whole cell configuration and 
acquired with sample frequency of 10 KHz. eEPSCs were filtered at half the acquisition rate with 8-
pole low-pass Bessel filter. Recording with leak current >100pA or series resistance >20M  were 
discarded. Analysis was performed with Clampfit software (Axon Instruments). Noise analysis on 
mEPSCs was performed with MiniAnalysis software (Synaptosoft, USA). Data are expressed as 
means ± S.E.M and statistical significance was calculated by using Student’s t-test. Values of p< 
0.05 were considered significant. 
Voltage clamp 
For currents dependent by NMDA administration, recording neurons were hold at -70mV (Vh) for 
the entire duration of the experiments. 
NMDA dependent EPSCs following spontaneous APs or electrical stimulation were recorded by 
holding neurons at voltages comprised between -70mV and +50mV. eEPSCs were recorded by 
delivering presynaptic electrical stimuli through a glass pipette (1 μm tip diameter) filled with 
Tyrode’s solution and placed in contact with the soma of presynaptic neuron in a loose-seal 
configuration. The minimum amplitude (10–45 μA) of current pulses of 0.1 ms duration was 
generated by an isolated pulse stimulator (model 2100; A-M Systems, USA). Postsynaptic neurons 
were hold at potentials comprised between -70 and + 50mV according to the typology of the 
experiment. 
Calcium imaging 
Hippocampal neurons plated on glass petri dishes were loaded with the fluorescent Ca2+ indicator 
Fura2-AM dye (3 μM) (Invitrogen, Molecular Probes, USA) in the extracellular solution for 1 hour. 
The fluorescent dye was then washed, and extracellular solution containing picrotoxin (100μM) was 
replaced into the petri dish. The inverted microscope used (Leica DMI3000B, Germany) was 
equipped with a short-arc xenon gas discharge lamp (Ushio, Cypress, USA). Alternating excitation 
wavelengths of 340 nm and 380 nm were obtained by a monochromator (Till Photonics, Germany). 
The emitted fluorescence was measured at 500-530 nm. Images were projected onto a EMCCD 
camera (QuantEM:512SC, Photometrics, USA) and stored every 200 ms. Spontaneous Ca2+ 
transients were recorded both in control condition and after incubation with Abeta42 using 
Metafluor software (Molecular Devices, USA) for data acquisition. The relative change in 
fluorescence ( F/F) was measured considering the peak of Ca2+ transients. 
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Solutions and drugs 
For voltage clamp recordings the external solution contained (in mM): 130 NaCl, 1.8 CaCl2, 10 
HEPES, 10 glucose, 1.2 Glicine (pH 7.4). The internal solution contained (in mM): 90 CsCl, 8 
NaCl, 20 TEACl, 10 EGTA, 10 Glucose, 1 MgCl, 4 ATP, 0.5 GTP, 15 Phosphocreatine (pH 7.4 
with CsOH). For blocking synaptic currents due to the activation of glutamatergic AMPARs and 
GABAergic synapses (GABAA receptors) we added respectively 6,7-dinitroquinoxaline-2,3-dione, 
DNQX (20 M, Sigma-Aldrich, USA) and picrotoxin (100 μM, Sigma-Aldrich). Tetrodotoxin 
(TTX 0.3 μM, Tocris Bioscience, UK) was added to block voltage-gated Na+ channels. Dantrolene 
(10 μM, Sigma-Aldrich) was added to block RyRs. (2R)-amino-5-phosphonopentanoate, APV (50 
μM, Sigma Aldrich) was added for blocking NMDARs.  
Statistics
Data are given as mean ± SEM for n number of cells. Statistical significance was estimated using 
either paired or unpaired Student’s t. Data were found statistically significant when P <0.05.
Results
Abeta42 oligomers decrease NMDAR inward currents without impairing ligand-receptor 
binding affinity 
Networks of primary cultured hippocampal neurons are known to generate spontaneous bursts of 
action potentials (APs) (Bacci et al., 1999; Gavello et al., 2012) that are modulated by inhibitory 
and excitatory synapses (Gavello et al., 2018). Glutamatergic synapses dependent on NMDARs 
activation (NMDA-driven synapses), are involved in the modulation of spontaneous network 
excitability and inhibited by Abeta42 oligomers (Gavello et al., 2018). As a first approach, we 
tested whether this inhibition affected pre or postsynaptic mechanisms. To this purpose, we 
compared NMDA-activated currents in control versus Abeta42-treated neurons. Patch clamp 
experiments, performed by holding neurons at Vh= -70 mV, showed that 50 μM NMDA induces a 
mean inward current of 352 ± 3 pA (n= 31) through NMDARs (INMDA) that is reduced to 117 ± 15 
pA (n= 23) by 1 μM Abeta42 (*** p<0.001) (Fig. 1a-c). Comparable decreases were obtained by 
varying NMDA concentration from 20 to 300 μM (Fig. 1c) or by decreasing the Abeta42 
concentration to 10 nM. Under this condition (not shown), we still observed that 10 nM Abeta42 
reduced INMDA by 30% with 50 μM NMDA (from 711 ± 79 pA, n= 17, to 487 ± 78 pA, n=15; 
p<0.05). Plots of INMDA versus [NMDA] (from 2 to 300 μM) exhibited dose-response relationship 
fitted by Hill equations of similar steepness (p) and IC50 (see Fig. 1d legend). The p values were 
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1.4±0.4 μM in control (ctr) and 1.5±0.4 μM in the presence of Abeta42 and the IC50 were 17.3 ± 3.3 
μM in control and 16.5±3.9 μM with Abeta42 (Fig. 1d). We thus concluded that Abeta42 inhibits 
the INMDA amplitude without significantly affecting the stoichiometry and the ligand-receptor 
binding affinity. 
Abeta42 decreases the number of NMDARs without altering their single channel conductance 
In order to understand how Abeta42 inhibits postsynaptic NMDA-activated currents we estimated 
the mean number of functioning NMDARs and their single channel conductance both in control and 
in the presence of Abeta42, by comparing the variance ( 2) of INMDA stationary noise (Sigworth, 
1980). We calculated 2 for periods of 2 s during stationary conditions of INMDA and plotted the 
values as a function of the average INMDA amplitudes generated by increased concentrations of 
NMDA (Traynelis & Jaramillo, 1998). The relationship between 2 and INMDA is described by the 
following parabolic equation: 2= iI - I2/n, where i is the unitary current of NMDARs, n the number 
of activated NMDARs and I the mean INMDA amplitude. We observed drastic lower values of INMDA 
amplitudes and 2 in neurons incubated with Abeta42 compared to control neurons (Fig. 2a-d). The 
fit with the above parabolic function gave a significantly decreased number of NMDARs (n) with 
Abeta42 (from 455 ± 66 to 249 ± 44 after incubation with Abeta42; *p<0.05) (Fig. 2e) and nearly 
similar values for the single channel unitary current (i) (1.9 ± 0.2 pA in control neurons and 1.8 ± 
0.2 pA in cells treated with Abeta42) (Fig. 2f). The corresponding single channel conductance of 
NMDARs were 19 and 20 pS, respectively in controls and Abeta42-treated neurons calculated 
assuming a reversal potential (Vrev) of +25 mV that was determined from the reversal potential of 
mEPSCs (Fig. 5a). Finally, we estimated the maximum open probability of NMDAR channels p= 
N/i (Traynelis & Jaramillo, 1998) and found no significant changes (p=0.83) between control (0.50 
± 0.05) and Abeta42 treated neurons (0.52 ± 0.06) (Fig. 2g). 
Abeta42 oligomers decrease [Ca2+]i but preserve the Ca2+-induced Ca2+ release coupling 
between NMDARs and RyRs 
Having previously shown that Abeta42 increases the amount of [Ca2+]i by targeting RyRs (Gavello 
et al., 2018), we wondered whether NMDARs, known to be permeable to Ca2+ (Emptage et al., 
1999), were involved in this process. Using Ca2+ imaging we quantified the [Ca2+]i increase induced 
by NMDA administration (50 μM) and its modulation by Abeta42, knowing that the mechanism of 
Ca2+-induced Ca2+ release (CICR) through RyRs activation is upregulated by Abeta42 (Gavello et 
al., 2018). We observed a marked increase of [Ca2+]i during NMDA application (Fig. 3a) that was 
fully abolished in the absence of extracellular Ca2+. In control neurons (Fig. 3b), NMDA induced an 
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approximately 8-fold increase of [Ca2+]i ( F/F= 7.9 ± 1.2, n= 25) that was nearly halved by 
Abeta42 ( F/F= 4.7 ± 0.4, n= 33; *p<0.05) (Fig. 3b-e).  
To quantify the involvement of RyRs in the CICR mechanism triggered by NMDA, we inhibited 
RyRs by applying 10 μM dantrolene (Zhao et al., 2001). Surprisingly enough, in control and 
Abeta42-treated neurons dantrolene reduced to nearly half the NMDA-induced [Ca2+]i increase. 
F/F decreased from 7.9±1.2 to 3.7±0.6 (n=33; **p<0.01) in control (Fig.3 b, d) and from 4.7±0.4 
to 2.4±0.3 (n=31;***p<0.001) (Fig. 3c,e) in Abeta42-treated neurons. These results confirm that the 
NMDA-mediated [Ca2+]i increase is nearly half associate to a CICR mechanism that involves RyRs 
and that this mechanism is not impaired by Abeta42. In fact, the [Ca2+]i increase associated to the 
RyRs is 40% of the total in control and raises to 49% with the oligomers. In addition, since Abeta42 
induces a potentiating effect on the Ca2+ released from RyRs, it is evident that the Abeta42 
prevailing effect is an overall decrease of the amount of [Ca2+]i following NMDARs activation.  
Abeta42 does not affect the number of release sites of NMDA-regulated synapses 
To gain further insights on the effects of Abeta42 on glutamatergic NMDA synapses, we measured 
the eEPSCs amplitude by holding neurons at +20 mV and varying the extracellular concentration of 
CdCl2 (6 to 2 μM) and CaCl2 (2 to 5 mM) to increase the release probability and thus increasing 
eEPSCs amplitudes (Fig. 4a) (Clements & Silver, 2000). By comparing the eEPSCs amplitudes 
(Fig. 4a,c,e) with those measured in neurons incubated with Abeta42 (Fig.4b,d,f), we found that the 
oligomer significantly increased the mean eEPSC amplitude (from 241 ± 27 pA, n=14, to 344 ± 40 
pA, n=19, * p<0.05, in the presence of 2 mM CaCl2) (Fig. 4g). We next performed multiple 
probability fluctuation analysis (MPFA) to estimate the number of release sites (N), the quantal size 
(q) and the release probability (p) of glutamatergic NMDA synapses (Silver et al., 1998; Clements 
& Silver, 2000; Baldelli et al., 2005). A parabolic function ( 2= AIav – BIav2) describes the 
relationship between the variance of eEPSCs amplitude ( 2) and their mean postsynaptic current 
amplitude values (Iav) (Fig. 4c, d). N was obtained from B (N= 1/B), while q was taken equal A. 
Finally, p was estimated considering that Iav= N p q. We observed that with Abeta42 N increased 
significantly from 137 ± 39 to 267 ± 51 (*p<0.05) (Fig. 4h), while q decreased from 6.1 ± 0.8 pA to 
4.0 ± 0.6 pA (*p<0.05) (Fig. 4i) and p, measured in 2 mM CaCl2, increased from 0.2 ± 0.02 to 0.3 ± 
0.03 (*p< 0.05). Thus, MPFA suggests that Abeta42 increases the number of release size while 
decreasing the quantal size of release. We next focused on the presynaptic effects of Abeta42, 
possibly responsible for the observed increased rate of glutamate release and in turn for the 
increased p as well as eEPSC amplitude. 
Abeta42 increases the amplitude and frequency of spontaneous EPSCs 
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Since spontaneous firing of hippocampal neurons is impaired by Abeta42 and NMDARs is involved 
in this process (Gavello et al., 2018), we next determined how the oligomers affect the amplitude 
and frequency of EPSCs generated at NMDA synapses during spontaneous APs at Vh varying from 
-70 to +50 mV. The EPSCs reversal potential was between +20 and + 30 mV and Abeta42 
increased significantly the average EPSCs amplitude at every potential (Fig. 5a-c). At Vh= -70 mV 
the average EPSCs amplitude in control neurons was -403 ± 65 pA (n=7), while in the presence of 
Abeta42 it increased to -826 ± 83 pA (n=13;** p<0.01) (Fig. 5a, inset). When the interevent 
intervals (IEIs) were considered (Fig. 5d,e), they were shorter and more regular in Abeta42 treated 
neurons. IEIs in control and Abeta42-treated neurons had rather different Gaussian distributions. 
Control IEIs were best fitted with a double Gaussian function, with peaks respectively at 662.8 and 
1841.3 ms (Fig. 5d), while IEIs in Abeta42-treated neurons were distributed according to a single 
Gaussian function with a peak at 1204 ms (Fig. 5e). The corresponding cumulative probability 
functions were significantly different (Kolmogrov Smirnov (KS) test ***p<0.001) (Fig. 5f) and the 
same was for the coefficient of variation (CV) of IEIs that decreased markedly in Abeta42-treated 
neurons (0.60 ± 0.03 in control neurons vs. 0.28 ± 0.03 with Abeta42; ***p<0.001) (Fig. 5g). Thus, 
Abeta42 besides increasing the EPSCs amplitude, increases their frequency and regularity of 
occurrence. 
Abeta42 increases synaptic depression during trains of stimuli 
To better analyze the effects of Abeta42 on synaptic function we next assayed the NMDA-mediated 
synaptic response to high frequency stimulation (10 Hz) for periods of 1.5 s (Schneggenburger et 
al., 2002; Baldelli et al., 2005). Following this protocol, the amplitude of the eEPSCs was maximal 
during the first pulse of the train and then progressively depressed until reaching a constant value 
during the last 5-6 pulses, when the eEPSC amplitude reaches steady-state conditions (Fig. 6a, top). 
There was no sign of facilitation both in control and in Abeta42-treated cells. Nevertheless, it was 
evident that the eEPSCs depression during the steady state phase was more pronounced in Abeta42-
treated neurons, despite the size of the first eEPSC was higher than in control conditions (Fig.6a, 
bottom). The increased synaptic depression in Abeta42 treated neurons was clearly visible when the 
normalized amplitude of eEPSCs was plotted vs. time (Fig. 6b) and fitted by a double exponential 
function with fast ( f) and slow ( s) time constants. We observed that f and s decreased in the 
presence of Abeta42, respectively from 0.97 and 32 ms (in control) to 0.30 and 13.4 ms with 
Abeta42. 
We next focused on the cumulative profile of eEPSC amplitudes observing in control and in 
Abeta42-treated neurons a rapid rise of cumulative eEPSCs followed by a steady-state linear 
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increase (Fig. 6c). This last linear phase reflects the equilibrium condition between vesicle release 
and vesicle replenishment. According to Schneggenburger et al, (2002) the intercept on the y-axis 
of the backward linear extrapolation of the last 5 to 6 points of the cumulative amplitude furnishes a 
likely estimate of the RRP size generating the eEPSCs. The linear fits of the cumulative amplitudes 
show clearly an increased size of RRP from 655 ± 143 pA (n=12) in control to 1040 ± 361 pA 
(n=11) in Abeta42-treated neurons (Fig. 6d). We could also estimate the release probability p that a 
vesicle is released from the RRP by calculating the ratio between the size of the first eEPSCs and 
the RRP and observed that Abeta42 significantly increased p from 0.67 ± 0.03 to 0.84 ± 0.08 
(*p<0.05) (Fig. 6e). 
Abeta42 oligomers increase the paired pulse depression of eEPSCs. 
To elucidate the presynaptic mechanism responsible for the increased eEPSCs amplitude induced 
by Abeta42, we tested whether the Abeta42-mediated increase of EPSCs influences the probability 
of Ca2+-dependent neurotransmitter release. We therefore estimated the percentage of paired pulse 
depression (PPD) of eEPSCs by electrically stimulating presynaptic neurons with pair of pulses 
separated by interpulse intervals of increasing duration (from 25 ms to 2 s) (Baldelli et al., 2002). 
Percentage of PPD plotted versus the interpulse interval duration decreased following a double 
exponential decay both in control and in Abeta42-treated neurons (Fig. 7a). Within the first 100 ms 
the PPD decreased from 55.4 ± 3.6 % to 39.3 ± 4.0 % (n= 21) in control (Fig. 7c and inset in Fig. 
7a), while in Abeta42 treated neurons it decreased from initial higher values: 72.8 ± 4.3 % to 52.8 ± 
5.6 %, n=13; *p<0.05). At interpulse intervals longer than 100 ms, PPD decayed with a slower time 
constant that was not significantly different between control and Abeta42-treated neurons. Since the 
magnitude of PPD at very brief interpulse intervals approximates the probability of release (p) 
(Dittman & Regehr, 1998), we can conclude that Abeta42 acts presynaptically by increasing the 
probability of glutamate release. 
When PPD was measured in the presence of dantrolene together with Abeta42, its amplitude and 
decay time were comparable to that measured in control neurons (Fig. 7b, e). This suggests that the 
increased probability of glutamate release with Abeta42 is most likely due to the amount of calcium 
released from RyRs that dantrolene effectively prevents. Finally, when comparing the average 
amplitude of the first eEPSC (Fig.7c, d) at Vh=-70 mV we could observe that Abeta42 causes a 
significant increase of the EPSC (from 320 ± 39 pA (n=13) to 466 ± 68 pA (n=9); *p<0.05), 




We provided evidence that Abeta42 impairs NMDAR-mediated glutamatergic synapses and targets 
both pre and postsynaptic sites. Abeta42 inhibits the average current amplitude generated by 
NMDARs activation by decreasing the number of postsynaptic NMDARs without altering their 
unitary current and open probability. These inhibitory postsynaptic effects decrease the amount of 
calcium entering into the cell through NMDARs and this apparently contrast with the previously 
reported increase of total Ca2+ released through RyRs induced by Abeta42 (Gavello et al., 2018). To 
clarify this issue we focused on EPSCs elicited by presynaptic electric stimulation or spontaneous 
APs. We unmasked a dual effect of Abeta42 that should not be ignored in the development of new 
therapies for AD treatment presently focused exclusively on NMDA synapses and based on the 
inhibition of NMDARs (Folch et al., 2017). We show that the postsynaptic inhibitory effect induced 
by Abeta42 on NMDA synapses opposes with the enhancing effect generated at the presynaptic 
site, where Abeta42 increases the eEPSCs amplitude by increasing the release probability of 
glutamate, the number of release sites and the size of the RRP of NMDA synapses. Finally, we have 
pointed out that RyRs inhibition restores the average amplitude of eEPSCs to values comparable to 
those measured in control neurons and abolishes the increased PPD induced by Abeta42. In 
agreement with our previous results (Gavello et al., 2018), we confirm that inhibition of RyRs 
could be a promising strategy for treating early symptoms of AD. 
Abeta42 decreases NMDA-activated inward current by reducing the number of postsynaptic 
NMDARs 
To distinguish the pre and postsynaptic effects induced by Abeta42 on NMDA glutamatergic 
synapses, we first focused on the postsynaptic effects on NMDARs. The inward current amplitude 
estimated during NMDA application is smaller if compared to the size of spontaneous EPSCs 
activated by synchronous glutamate release (Fig. 1, 5). This is in good agreement with the well-
known property that NAMDRs are more sensitive to glutamate than to NMDA (Monyer et al., 
1992). Given this, we have shown that, the oligomer decreases the expression of functionally active 
NMDARs without modifying the unitary current and open probability of the channel (Fig. 2). 
Interestingly, the estimated NMDARs single channel conductance (20 pS) appears comparable to 
that measured in Xenopus oocytes (ref) or obtained by using a similar approach (21-35 pS) (Kohr et 
al., 1993) and is in reasonable agreement with that measured in single channel out-side-out patches 
of dissociated hippocampal neurons from neonatal rats (40-50 pS) (Jahr & Stevens, 1987; Bekkers 
& Stevens, 1989).  
Our findings are also in line with the idea of a downregulation of the non amyloidogenic pathway of 
APP processing during AD (Snyder et al., 2005; Shankar et al., 2007) with consequent altered 
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synaptic plasticity and neuronal survival (Hoey et al., 2009). The non amyloidogenic pathway is 
upregulated by Ca2+ entering through NMDARs and the decreased Ca2+ influx through these 
receptors induced by Abeta42 contributes to exacerbate the early impairments induced by the 
oligomer. Abeta oligomers cause the inhibition of LTP (Lambert et al., 1998) and, given the 
importance of Ca2+ influx through NMDARs in modulating spine formation, the decreased Ca2+ 
influx through NMDARs and consequent reduction of spine density induced by the oligomers 
(Shankar et al., 2007) are likely the triggering events of impaired learning and memory in AD. 
Here, we provide further explanation on the mechanism of action of Abeta42 on postsynaptic 
NMDARs in determining hippocampal synaptic dysfunction by reducing the expression density of 
these receptors. 
Abeta42 decreases the amount of [Ca2+]i triggered by NMDARs activation but preserves the 
Ca2+ induced-Ca2+ release coupling to RyRs 
Our findings on the [Ca2+]i increase induced by NMDA nicely correlate with patch clamp 
experiments and show that INMDA inhibition by Abeta42 is accompanied by a proportional decrease 
of the Ca2+ entering through NMDARs. In neurons, a CICR coupling that triggers Ca2+ release from 
the endoplasmic reticulum via RyRs and IP3 receptors (Emptage et al., 1999) accompanies this 
process. We aimed to correlate this result with our recently published findings on the overall 
increase of [Ca2+]i induced by Abeta42 (Gavello et al., 2018) and wondered whether the CICR 
coupling triggered by NMDARs was impaired by Abeta42. Our data indicate that, independently of 
the presence of Abeta42, Ca2+ released from RyRs account for half of the total [Ca2+]i increase and 
concluded that Abeta42 does not interfere with this mechanism of CICR. We therefore suggest that 
differently from what previously observed by others (Goussakov et al., 2010), Ca2+ released from 
RyRs following NMDARs activation is not responsible for the increased [Ca2+]i induced by 
Abeta42, possibly reflecting the different experimental model used in the experiments. We suggest 
that other Ca2+ sources responsible for potentiating Ca2+ release from RyRs are likely to be 
involved, like the VGCCs that are downregulated by Abeta42 (Gavello et al., 2018), or IP3 
receptors, known to be modulated by RyRs (Berridge, 2011) and to be impaired in some AD mouse 
model (Stutzmann et al., 2004). Alternatively, the existence of calcium leak phenomena coupled to 
RyRs should also be considered (Lacampagne et al., 2017). 
Abeta42 increases the size of eEPSCs triggered by NMDARs activation 
Using multiple probability fluctuation analysis (MPFA) (Clements & Silver, 2000) we could 
estimate the average number of synaptic release sites (N), the release probability (p) and the quantal 
size (q). Visual inspection of the shape of parabolic variance-mean plot (Clements & Silver, 2000) 
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reveals that the initial slope of the parabola is lowered by Abeta42 (Fig. 4), suggesting a decreased 
q, which is in line with the decreased number of NMDARs estimated in Abeta42-treated neurons. 
Moreover, the degree of curvature of the same parabola is higher in the presence of Abeta42, 
confirming the increased p. This is in line with the analysis of cumulative EPSCs (Fig. 6) and 
increased PPD (Fig. 7). Finally, Abeta42 increases the size of the parabola that depends on N (Fig. 
4h). 
In addition to this, voltage-clamp experiments provide evidence that, differently from what 
observed during direct application of NMDA (Fig. 1), neurons incubated with Abeta42 exhibit 
increased eEPSCs amplitude. This is at variance from what we observed on AMPA synapses 
(Gavello et al., 2018) where eEPSCs amplitude are potentiated by Abeta42 only in the presence of 
RyRs or BK channels inhibitor indicating the existence of a “braking” action of calcium released 
from RyRs as already observed in 3xTg-AD mice (Chakroborty et al., 2009). This suggests 
different effects induced by increasing release of Ca2+ from RyRs on AMPA or NMDA synapses 
and underlie the need of an in-depth characterization of synaptic dysfunctions induced by Abeta42. 
A potentiating effect of Abeta42 on the EPSCs size is also evident by observing the larger 
amplitude, higher frequency and increased regularity of spontaneous EPSCs in the presence of 
Abeta42 (Fig. 5). All this suggests that Abeta42 is likely responsible for a presynaptic Ca2+-
dependent potentiating effect of glutamatergic synapses. Of particular interest is the increased 
regularity of spontaneous EPSCs induced by Abeta42. To this regard, it has been reported that in 
dopaminergic neurons the firing rate and regularity of firing are under the control of SK channels 
(Iyer et al., 2017). Thus, it is likely that the increased [Ca2+]i induced by Abeta42 activates robust 
SK currents that regulate spontaneous firing and synaptic function of hippocampal networks 
(Lancaster & Adams, 1986; Stocker et al., 1999). SK channels are of relevance for controlling 
various brain function like motor coordination (Walter et al., 2006). 
Abeta42 increases the probability of glutamate release and reduces the ability of NMDA 
synapses to sustain prolonged stimulation 
The study of the effects of Abeta42 on p has been deeper investigated by measuring the paired pulse 
ratio (PPR) and the corresponding PPD. Hippocampal NMDA synapses are characterized by a net 
synaptic depression which can be regulated by either NMDARs desensitization (Mennerick & 
Zorumski, 1996) or activation of presynaptic GABAB receptors (Huang & Gean, 1994). This short-
term synaptic plasticity slows down the firing rate of hippocampal network. To this regard, we have 
previously shown (Gavello et al., 2018) that the spontaneous firing of cultured hippocampal 
neurons is characterized by bursts of APs of 600 ms duration at 50 Hz intraburst firing frequency, 
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that corresponds to an average time interval of 20 ms between APs. If we consider that Abeta42 
significantly increases the PPD during 25 to 100 ms, we expect a consistent inhibition of AP firing 
with Abeta42, in agreement with the reduced number of bursts and burst duration detected by 
MEAs (Gavello et al., 2018). This inhibitory effect is in line with what already observed in Tg2576 
mice overexpressing Abeta peptides (Marcantoni et al., 2014). 
While our data reveal that Abeta42 increases the release probability (p) during paired pulses 
separated by 25 to 100 ms, it is evident that synapses treated with Abeta42 are unable to sustain 
prolonged stimulations during repetitive pulses at 10 Hz (Fig.6). This occurs if the increased p 
induced by the oligomers determines a rapid empty of vesicles, not followed by a fast replenishment 
as it occurs in hippocampal GABAergic interneurons after BDNF incubation (Baldelli et al., 2005). 
It should also be considered that the high frequency stimulation (10 Hz) used in our voltage-clamp 
experiments is 5-fold lower than the effective AP frequency measured by MEAs during the train of 
APs within a burst (50 Hz). This suggests that in more physiological conditions the effect of 
Abeta42 on NMDA synapses during fast and prolonged stimulation would be more pronounced in 
the overall firing inhibition. 
Taken all together, we can conclude that the potentiating presynaptic effects of Abeta42 reported 
here strongly depend on the increased amount of Ca2+ released from RyRs. To this regard, the 
observation that dantrolene reverts the increased PPD induced by Abeta42 (Fig. 7) is in line with 
the previously reported effect of dantrolene that prevents the Abeta42-dependent increase of 
eEPSCs amplitude, the elevation of [Ca2+]i  and the inhibition of firing (Gavello et al., 2018). This 
effective action of RyR inhibitors on glutamatergic synapses allows concluding that a 
pharmacological therapy based on the development of selective RyRs blockers have solid molecular 
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a) Representative inward current activated by NMDA (50μM) recorded in patch clamp experiment 
on primary cultured hippocampal neurons by holding neurons at Vh=-70mV. b) When neurons are 
incubated for 48h with Abeta42 the current activate by NMDA administration is significantly 
inhibited. c) Bar graphes summarizing the inhibitory effect induced by Abeta42 on inward currents 
activated by different concentrations of NMDA (from 20 to 300 μM). d) The dose response sigmoid 
curve of the current activated by NMDA (from 2 to 300 μM) is not affected by Abeta42. 
Fig.2 
a) In control neurons NMDA administration activates inward currents of increased amplitude 
depending by the increased concentration of the agonist (from 20 to 300 μM). The insets show the 
noise signal that increases together with the increased current amplitudes. b) Abeta42 decreases the 
amplitude of inward currents activated by increasing concentrations of NMDA as well as the noise 
signal. c) Representative parabolic relationship between the variance ( 2) of noise signal and mean 
of the inward current activated by NMDA at different concentrations in control neurons and in the 
presence of Abeta42 (d). e) Bar graph summarizing the significant decrease of the average number 
of NMDARs induced by Abea42, despite their unitary current (f) and open probability (g) remain 
unchanged. 
Fig.3 
a) In calcium imaging experiments performed in control neurons NMDA (50μM) increases [Ca2+]i 
when neurons are perfused with extracellular Tyrode standard solution containing 2mM Ca2+, while 
this effect is reversibly abolished in the absence of Ca2+ (0 Ca2+) in the extracellular medium. b) In 
control neurons the inhibition of RyRs through dantrolene (10 μM) halved the effect induced by 
NMDA. c) Abeta42 reduced by 50% the effect induced by NMDA on [Ca2+]i and, similarly to 
control neurons, dantrolene halved the effect induced by NMDA. d) Bar graph summarizing the 
effect induced by NMDA (50μM) on [Ca2+]i in control neurons and the related contribution of RyRs 
estimated by administration of dantrolene. e) Similarly to (d) the bar graph summarizes the effect 





a) Thirty overlapped eEPSCs traces dependent by NMDARs activation recorded in control neurons 
under different release probability conditions recorded by varying the concentrations of CaCl2 or 
CdCl2 in the external medium in order to change the release probability conditions. b) Thirty 
overlapped eEPSCs traces recorded after incubation of neurons with Abeta42 under different 
release probability conditions similarly to what shown in (a). c) Parabolic distribution of 2 in 
function of eEPSCs amplitude recorded in control neurons. d) Parabolic distribution of 2 in 
function of eEPSCs amplitude recorded in neurons incubated with Abeta42. e) Peak amplitude of 
eEPSCs recorded in control neurons in function of different concentrations of cadmium or calcium 
in the external medium f) Peak amplitude of eEPSCs recorded in neurons incubated with Abeta42 
in function of different concentrations of cadmium or calcium in the external medium. g) Bar graph 
of the average amplitude of eEPSCs recorded at +20mV with 2mM Ca2+ in the external medium, h) 
of the number of release sites, i) of the quantal size, and l) of the release probability of NMDA 
synapses in control neurons and in the presence of Abeta42.  
 
Fig.5 
a) Mean EPSCs amplitude evoked by spontaneous action potentials measured in control neurons 
and after administration of Abeta42 by holding neurons at membrane potentials comprised between 
-70 and +50 mV. b, c) Spontaneous EPSCs recorded in control neuron and in the presence of 
Abeta42 by holding neurons at membrane potentials comprised between -70 and + 50 mV. d, e) 
Histograms showing the distribution of EPSCs in function of inter event intervals (IEI) in control 
neurons and in the presence of Abeta42. f) Cumulative IEIs distribution of spontaneous EPSCs in 
control neurons and in neurons incubated with Abeta42. g) Bar graph of the coefficient of variation 
of IEIs in control neurons and in the presence of Abeta42. 
Fig.6 
a) eEPSCs recorded in control (top, black) and Abeta42 (bottom, grey) treated neurons by 
delivering repetitive constant pulses of current at 10Hz for 1.5 s. b) Normalized eEPSCs amplitude 
in function of time. c) Cumulative amplitude distribution of eEPSCs in function of time in control 
and after incubation of neurons with Abeta42. The final portion of the distribution follows a linear 
distribution. The intercept of the linear fit with y-axes provides a quantification of RRP size. d, e) 




a) Mean PPD (Paired Pulse Depression) values plotted in function of IEIs of different duration 
(comprised between 25 and 2000 ms). The inset shows at higher magnification the PPD values 
calculated for IEIs between 25 and 100ms. b) mean PPD values recorded after administration of 
dantrolene to neurons incubated with Abeta42. c-e) Paired eEPSCs recorded by setting the IEI at 25 
and 100 ms in control neurons (c), in neurons treated with Abeta42 (d) and in neurons treated with 
Abeta42 together with dantrolene (e). 
 
